Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic

被引：69

作者：

Katsiki, Niki ^{[1
]}

Banach, Maciej ^{[2
,3
]}

Mikhailidis, Dimitri P. ^{[4
]}

机构：

[1] Ahepa Univ Hosp, Dept Internal Med 1, Ctr Diabet, Div Endocrinol & Metab, Thessaloniki, Greece

[2] Univ Zielona Gora, Cardiovasc Res Ctr, Zielona Gora, Poland

[3] PMMHRI, Lodz, Poland

[4] UCL, Dept Clin Biochem, Sch Med, Royal Free Hosp Campus, London NW3 2QG, England

来源：

ARCHIVES OF MEDICAL SCIENCE | 2020年 / 16卷 / 03期

关键词：

RESPIRATORY-DISTRESS-SYNDROME; CARDIOVASCULAR RISK; RECEPTOR BLOCKERS; STATINS; INJURY; ROSUVASTATIN; SEPSIS;

D O I：

10.5114/aoms.2020.94503

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

[No abstract available]

引用

页码：485 / 489

页数：5

共 59 条

[1]

Effect of statins on toll-like receptors: a new insight to pleiotropic effects [J].

Bahrami, Afsane ;

Parsamanesh, Negin ;

Atkin, Stephen L. ;

Banach, Maciej ;

Sahebkar, Amirhossein .

PHARMACOLOGICAL RESEARCH, 2018, 135 :230-238

[2]

What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcome trials: ODYSSEY and FOURIER? [J].

Banach, Maciej ;

Penson, Peter E. .

CARDIOVASCULAR RESEARCH, 2019, 115 (03) :E26-E31

[3]

Statin non-adherence and residual cardiovascular risk: There is need for substantial improvement [J].

Banach, Maciej ;

Stulc, Tomas ;

Dent, Ricardo ;

Toth, Peter P. .

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 225 :184-196

[4]

Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel [J].

Banach, Maciej ;

Rizzo, Manfredi ;

Toth, Peter P. ;

Farnier, Michel ;

Davidson, Michael H. ;

Al-Rasadi, Khalid ;

Aronow, Wilbert S. ;

Athyros, Vasilis ;

Djuric, Dragan M. ;

Ezhov, Marat V. ;

Greenfield, Robert S. ;

Hovingh, G. Kees ;

Kostner, Karam ;

Serban, Corina ;

Lighezan, Daniel ;

Fras, Zlatko ;

Moriarty, Patrick M. ;

Muntner, Paul ;

Goudev, Assen ;

Ceska, Richard ;

Nicholls, Stephen J. ;

Broncel, Marlena ;

Nikolic, Dragana ;

Pella, Daniel ;

Puri, Raman ;

Rysz, Jacek ;

Wong, Nathan D. ;

Bajnok, Laszlo ;

Jones, Steven R. ;

Ray, Kausik K. ;

Mikhailidis, Dimitri P. .

ARCHIVES OF MEDICAL SCIENCE, 2015, 11 (01) :1-23

[5]

The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy-5-year follow-up [J].

Bielecka-Dabrowa, Agata ;

Mikhailidis, Dimitri P. ;

Rizzo, Manfredi ;

von Haehling, Stephan ;

Rysz, Jacek ;

Banach, Maciej .

LIPIDS IN HEALTH AND DISEASE, 2013, 12

[6]

Identification and validation of distinct biological phenotypes in patients with acute respiratory distress syndrome by cluster analysis [J].

Bos, L. D. ;

Schouten, L. R. ;

van Vught, L. A. ;

Wiewel, M. A. ;

Ong, D. S. Y. ;

Cremer, O. ;

Artigas, A. ;

Martin-Loeches, I. ;

Hoogendijk, A. J. ;

van der Poll, T. ;

Horn, J. ;

Juffermans, N. ;

Calfee, C. S. ;

Schultz, M. J. .

THORAX, 2017, 72 (10) :876-883

[7]

Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial [J].

Calfee, Carolyn S. ;

Delucchi, Kevin L. ;

Sinha, Pratik ;

Matthay, Michael A. ;

Hackett, Jonathan ;

Shankar-Hari, Manu ;

McDowell, Cliona ;

Laffey, John G. ;

O'Kane, Cecilia M. ;

McAuley, Daniel F. .

LANCET RESPIRATORY MEDICINE, 2018, 6 (09) :691-698

[8]

Angiotensin-converting enzyme 2 as a therapeutic target for heart failure [J].

Chamsi-Pasha M.A.R. ;

Shao Z. ;

Tang W.H.W. .

Current Heart Failure Reports, 2014, 11 (1) :58-63

[9]

Del Fiorentino A, 2009, VASC HEALTH RISK MAN, V5, P233

[10]

Deng YT, 2020, CAMB CHINA LIBR, P1

← 1 2 3 4 5 6 →